Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug-drug interaction study of AJM300 with midazolam, prednisolone, and atorvastatin in healthy males
jRCT2071230023Phase 1Completed
- Sponsor
- EA Pharma Co., Ltd.
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of firategrast in autoimmune colitis (5 arms), sponsored by EA Pharma Co., Ltd. Primary endpoints: Safety endpoints and Pharmacokinetic endpoints. Started Nov 2015; status: completed.
02
Drugs
firategrast
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCT2071230023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071230023.